Skip to main content

MARSHALL WACE, LLP

Position in ZTS — Zoetis Inc.

CIK 1318757 LONDON, X0

Position in ZTS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$18,501,794
+$17,883,911 QoQ
Shares Held
257,470
+4825.8% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#163
of 1,408 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Derivatives in ZTS

reported options exposure · as of Mar 31, 2026
CallValue
$11,821
CallShares
100
PutValue
$29,706,173
PutShares
251,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. ZTS ranks #8 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 ZTS
Zoetis Inc.
This page
257,470 $18,501,794

All Filings in ZTS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,501,794 257,470
2026-03-31 $617,883 5,227
2026-03-31 $11,821 100
2026-03-31 $29,706,173 251,300
2025-09-30 $86,969,680 594,380
2025-06-30 $6,734,544 43,184
2025-03-31 $59,865,257 363,591
2024-12-31 $128,458,735 788,429
2024-09-30 $158,790,600 812,727
2024-06-30 $144,874,176 835,684
2024-03-31 $1,834,405 10,841
2023-12-31 $572,373 2,900
2023-09-30 $30,104,629 173,035
2023-06-30 $15,918,575 92,437
2022-12-31 $1,450,698 9,899
2022-09-30 $93,074,217 627,650
2022-06-30 $43,162,265 251,104
2022-03-31 $113,067,436 599,541
2021-12-31 $278,875,775 1,142,793
2021-09-30 $116,704,737 601,137
2021-06-30 $177,281,472 951,285
2021-03-31 $270,609,694 1,718,375
2020-12-31 $474,140,784 2,864,899
2020-09-30 $380,358,937 2,300,048
2020-06-30 $289,809,999 2,114,784
2020-03-31 $201,271,083 1,710,180